Home » Newsletters » BioWorld Asia

BioWorld Asia

June 3, 1998

View Archived Issues

Canadian Start-Ups Increase With Surge In Venture Capital

Exiqon Spins Off Firm For Drugs That Mimic Nucleic Acids

Australia Earmarking A$20M To Boost Biotech Industry

EU Renews Efforts To Adopt Orphan Drug Regulations

Karo Bio Extends Alliance With UC Collaborators

Former Pharma Execs Bringing European Biotech To Japan

Progen Shares Surge, Retreat As Cancer Drug Enters Phase I

Inex Mouse Data Promising On Cancer Gene Therapy

Interferon Gene Therapy Beats HIV In Lab Studies

EU Explains 'Exceptional' Approval For Ares' Rebif

Other News to Note

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...